Back to search

Article

Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding

2024-11-17

Abstract excerpt

<h4>ABSTRACT</h4> Small molecule kinase inhibitors are critical in the modern treatment of cancers, evidenced by the existence of over 80 FDA-approved small-molecule kinase inhibitors. Unfortunately, intrinsic or acquired resistance, often causing therapy discontinuation, is frequently caused by mutations in the kinase therapeutic target. The advent of clinical tumor sequencing has opened additional opportunities...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b57fd83d-9278-53b1-a6a7-b41b212ef138
DOI
10.1101/2024.11.15.623861
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor bindingDOI 10.1101/2024.11.15.623861
Select a neighboring publication to make it the new centre.